Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2551-2560

  Boland, Brigid S ^a,b   Widjaja, Christella E ^a   Banno, Asoka ^a   Zhang, Bing ^a   Kim, Stephanie H ^a   Stoven, Samantha ^c   Peterson, Michael R ^d   Jones, Marilyn C ^e   Su, H Irene ^b   Crowe, Sheila E ^a   Bui, Jack D ^f   Ho, Samuel B ^g   Okugawa, Yoshinaga ^h,i   Goel, Ajay ^h,i   Marietta, Eric V ^c   Khosroheidari, Mahdieh ^b   Jepsen, Kristen ^b   Aramburu, Jose ^j   López Rodríguez, Cristina ^j   Sandborn, William J ^a,b   Murray, Joseph A ^c   Harismendy, Olivier ^a,k   Chang, John T ^a,b   more..

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

^d Multicare Health System   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^h BAYLOR RESEARCH INSTITUTE   (United States)

ⁱ BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITAT POMPEU FABRA   (Spain)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AZATHIOPRINE; CD16 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CORTICOSTEROID DERIVATIVE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; MERCAPTOPURINE; MESALAZINE; THIOGUANOSINE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; NFAT5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ABDOMINAL PAIN; ADAPTIVE IMMUNITY; ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENTEROCOLOPATHY; AUTOIMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; DNA METHYLATION; DNA SEQUENCE; DRUG EFFICACY; ECZEMA; ENTEROPATHY; FEVER; GENE; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; HAPLOIDY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEROSMOTIC STRESS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE CELL; LUNG INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOSIS; MALE; MOUSE; NATURAL KILLER CELL; NFAT5 GENE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SINOPULMONARY INFECTION; YOUNG ADULT; 129 MOUSE; ANIMAL; AUTOIMMUNE DISEASES; CASE REPORT; CELL CULTURE; DNA MUTATIONAL ANALYSIS; GASTROINTESTINAL DISEASES; GENETICS; HAPLOINSUFFICIENCY; IMMUNOBLOTTING; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; JURKAT CELL LINE; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DNA MUTATIONAL ANALYSIS; GASTROINTESTINAL DISEASES; GENE EXPRESSION; HAPLOINSUFFICIENCY; HUMANS; IMMUNOBLOTTING; IMMUNOLOGIC DEFICIENCY SYNDROMES; JURKAT CELLS; KILLER CELLS, NATURAL; MALE; MICE, 129 STRAIN; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84924559554     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401463     Document Type: Article

References (39)

1. Grammatikos, A. P., and G. C. Tsokos. 2012. Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends Mol. Med. 18: 101-108.
2. Verbsky, J. W., and T. A. Chatila. 2011. T-regulatory cells in primary immune deficiencies. Curr. Opin. Allergy Clin. Immunol. 11: 539-544.
3. Rosen, F. S., M. D. Cooper, and R. J. Wedgwood. 1995. The primary immunodeficiencies. N. Engl. J. Med. 333: 431-440.
4. Etzioni, A. 2003. Immune deficiency and autoimmunity. Autoimmun. Rev. 2: 364-369.
5. Akram, S., J. A. Murray, D. S. Pardi, G. L. Alexander, J. A. Schaffner, P. A. Russo, and S. C. Abraham. 2007. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin. Gastroenterol. Hepatol. 5: 1282-1290, quiz 1245.
6. Catassi, C., E. Fabiani, M. I. Spagnuolo, G. Barera, and A. Guarino, Working Group of the Italian Society of Pediatric Gastroenterology and Hepatology (SIGEP). 1999. Severe and protracted diarrhea: results of the 3-year SIGEP multicenter survey. J. Pediatr. Gastroenterol. Nutr. 29: 63-68.
7. Unsworth, D. J., and J. A. Walker-Smith. 1985. Autoimmunity in diarrhoeal disease. J. Pediatr. Gastroenterol. Nutr. 4: 375-380.
8. Singhi, A. D., A. Goyal, J. M. Davison, M. D. Regueiro, R. L. Roche, and S. Ranganathan. 2014. Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency disorders. Mod. Pathol. 27: 543-553.
9. Buxadé, M., G. Lunazzi, J. Minguillón, S. Iborra, R. Berga-Bolaños, M. Del Val, J. Aramburu, and C. López-Rodríguez. 2012. Gene expression induced by Tolllike receptors in macrophages requires the transcription factor NFAT5. J. Exp. Med. 209: 379-393.
10. Drews-Elger, K., M. C. Ortells, A. Rao, C. López-Rodriguez, and J. Aramburu. 2009. The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress. PLoS ONE 4: e5245.
11. Esensten, J. H., A. V. Tsytsykova, C. Lopez-Rodriguez, F. A. Ligeiro, A. Rao, and A. E. Goldfeld. 2005. NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone. Nucleic Acids Res. 33: 3845-3854.
12. Lopez-Rodríguez, C., J. Aramburu, A. S. Rakeman, and A. Rao. 1999. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl. Acad. Sci. USA 96: 7214-7219.
13. Miyakawa, H., S. K. Woo, S. C. Dahl, J. S. Handler, and H. M. Kwon. 1999. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl. Acad. Sci. USA 96: 2538-2542.
14. López-Rodríguez, C., J. Aramburu, L. Jin, A. S. Rakeman, M. Michino, and A. Rao. 2001. Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 15: 47-58.
15. Trama, J., W. Y. Go, and S. N. Ho. 2002. The osmoprotective function of the NFAT5 transcription factor in T cell development and activation. J. Immunol. 169: 5477-5488.
16. Berga-Bolaños, R., K. Drews-Elger, J. Aramburu, and C. López-Rodríguez. 2010. NFAT5 regulates T lymphocyte homeostasis and CD24-dependent T cell expansion under pathologic hypernatremia. J. Immunol. 185: 6624-6635.
17. Trama, J., Q. Lu, R. G. Hawley, and S. N. Ho. 2000. The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurindependent manner. J. Immunol. 165: 4884-4894.
18. Go, W. Y., X. Liu, M. A. Roti, F. Liu, and S. N. Ho. 2004. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl. Acad. Sci. USA 101: 10673-10678.
19. López-Rodríguez, C., C. L. Antos, J. M. Shelton, J. A. Richardson, F. Lin, T. I. Novobrantseva, R. T. Bronson, P. Igarashi, A. Rao, and E. N. Olson. 2004. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc. Natl. Acad. Sci. USA 101: 2392-2397.
20. Sherry, S. T., M. H. Ward, M. Kholodov, J. Baker, L. Phan, E. M. Smigielski, and K. Sirotkin. 2001. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29: 308-311.
21. Goel, A., R. M. Xicola, T. P. Nguyen, B. J. Doyle, V. R. Sohn, P. Bandipalliam, L. S. Rozek, J. Reyes, C. Cordero, F. Balaguer, et al. 2010. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology 138: 1854-1862.
22. Fellmann, C., J. Zuber, K. McJunkin, K. Chang, C. D. Malone, R. A. Dickins, Q. Xu, M. O. Hengartner, S. J. Elledge, G. J. Hannon, and S. W. Lowe. 2011. Functional identification of optimized RNAi triggers using a massively parallel sensor assay. Mol. Cell 41: 733-746.
23. Chang, J. T., V. R. Palanivel, I. Kinjyo, F. Schambach, A. M. Intlekofer, A. Banerjee, S. A. Longworth, K. E. Vinup, P. Mrass, J. Oliaro, et al. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315: 1687-1691.
24. Bamias, G., D. Goukos, E. Laoudi, I. G. Balla, S. I. Siakavellas, G. L. Daikos, and S. D. Ladas. 2013. Comparative study of candidate housekeeping genes for quantification of target gene messenger RNA expression by real-time PCR in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 19: 2840-2847.
25. Hamer, H. M., D. M. Jonkers, S. A. Vanhoutvin, F. J. Troost, G. Rijkers, A. de Bruïne, A. Bast, K. Venema, and R. J. Brummer. 2010. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin. Nutr. 29: 738-744.
26. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190: 75-89.
27. Sanz, I., C. Wei, F. E. Lee, and J. Anolik. 2008. Phenotypic and functional heterogeneity of human memory B cells. Semin. Immunol. 20: 67-82.
28. Dubinsky, M. C., S. Lamothe, H. Y. Yang, S. R. Targan, D. Sinnett, Y. Théorêt, and E. G. Seidman. 2000. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118: 705-713.
29. Osterman, M. T., R. Kundu, G. R. Lichtenstein, and J. D. Lewis. 2006. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology 130: 1047-1053.
30. Wright, S., D. S. Sanders, A. J. Lobo, and L. Lennard. 2004. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease. Gut 53: 1123-1128.
31. Kleinewietfeld, M., A. Manzel, J. Titze, H. Kvakan, N. Yosef, R. A. Linker, D. N. Muller, and D. A. Hafler. 2013. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496: 518-522.
32. Wu, C., N. Yosef, T. Thalhamer, C. Zhu, S. Xiao, Y. Kishi, A. Regev, and V. K. Kuchroo. 2013. Induction of pathogenic TH17 cells by inducible saltsensing kinase SGK1. Nature 496: 513-517.
33. Lapunzina, P., and D. Monk. 2011. The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancer. Biol. Cell 103: 303-317.
34. Spence, J. E., R. G. Perciaccante, G. M. Greig, H. F. Willard, D. H. Ledbetter, J. F. Hejtmancik, M. S. Pollack, W. E. O'Brien, and A. L. Beaudet. 1988. Uniparental disomy as a mechanism for human genetic disease. Am. J. Hum. Genet. 42: 217-226.
35. Schilli, R., R. I. Breuer, F. Klein, K. Dunn, A. Gnaedinger, J. Bernstein, M. Paige, and M. Kaufman. 1982. Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis. Gut 23: 326-332.
36. Kino, T., H. Takatori, I. Manoli, Y. Wang, A. Tiulpakov, M. R. Blackman, Y. A. Su, G. P. Chrousos, A. H. DeCherney, and J. H. Segars. 2009. Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci. Signal. 2: ra5.
37. Oxelius, V. A. 1984. Immunoglobulin G (IgG) subclasses and human disease. Am. J. Med. 76(3A): 7-18.
38. Shackelford, P. G., S. H. Polmar, J. L. Mayus, W. L. Johnson, J. M. Corry, and M. H. Nahm. 1986. Spectrum of IgG2 subclass deficiency in children with recurrent infections: prospective study. J. Pediatr. 108: 647-653.
39. Siber, G. R., P. H. Schur, A. C. Aisenberg, S. A. Weitzman, and G. Schiffman. 1980. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engl. J. Med. 303: 178-182.